These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 32296843)
1. SMARCB1 Gene Mutation Predisposes to Earlier Development of Glioblastoma: A Case Report of Familial GBM. Mukherjee S; Stroberg E; Wang F; Morales L; Shan Y; Rao A; Huang JH; Wu E; Fonkem E J Neuropathol Exp Neurol; 2020 May; 79(5):562-565. PubMed ID: 32296843 [TBL] [Abstract][Full Text] [Related]
2. Authors' Reply: SMARCB1 Gene Mutation Predisposes to Earlier Development of Glioblastoma: A Case Report of Familial GBM. Fonkem E; Peng S; Berens M; Mukherjee S J Neuropathol Exp Neurol; 2021 Feb; 80(3):290-291. PubMed ID: 33617648 [No Abstract] [Full Text] [Related]
3. New insights into the genetics of glioblastoma multiforme by familial exome sequencing. Backes C; Harz C; Fischer U; Schmitt J; Ludwig N; Petersen BS; Mueller SC; Kim YJ; Wolf NM; Katus HA; Meder B; Furtwängler R; Franke A; Bohle R; Henn W; Graf N; Keller A; Meese E Oncotarget; 2015 Mar; 6(8):5918-31. PubMed ID: 25537509 [TBL] [Abstract][Full Text] [Related]
4. Comment on: SMARCB1 Gene Mutation Predisposes to Earlier Development of Glioblastoma: A Case Report of Familial GBM. Smith MJ; Pathmanaban ON; Coope DJ; King AT; Evans DG J Neuropathol Exp Neurol; 2021 Feb; 80(3):289-290. PubMed ID: 33617649 [No Abstract] [Full Text] [Related]
5. Discovering gene-environment interactions in glioblastoma through a comprehensive data integration bioinformatics method. Kunkle B; Yoo C; Roy D Neurotoxicology; 2013 Mar; 35():1-14. PubMed ID: 23261424 [TBL] [Abstract][Full Text] [Related]
6. Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma. Sturm D; Witt H; Hovestadt V; Khuong-Quang DA; Jones DT; Konermann C; Pfaff E; Tönjes M; Sill M; Bender S; Kool M; Zapatka M; Becker N; Zucknick M; Hielscher T; Liu XY; Fontebasso AM; Ryzhova M; Albrecht S; Jacob K; Wolter M; Ebinger M; Schuhmann MU; van Meter T; Frühwald MC; Hauch H; Pekrun A; Radlwimmer B; Niehues T; von Komorowski G; Dürken M; Kulozik AE; Madden J; Donson A; Foreman NK; Drissi R; Fouladi M; Scheurlen W; von Deimling A; Monoranu C; Roggendorf W; Herold-Mende C; Unterberg A; Kramm CM; Felsberg J; Hartmann C; Wiestler B; Wick W; Milde T; Witt O; Lindroth AM; Schwartzentruber J; Faury D; Fleming A; Zakrzewska M; Liberski PP; Zakrzewski K; Hauser P; Garami M; Klekner A; Bognar L; Morrissy S; Cavalli F; Taylor MD; van Sluis P; Koster J; Versteeg R; Volckmann R; Mikkelsen T; Aldape K; Reifenberger G; Collins VP; Majewski J; Korshunov A; Lichter P; Plass C; Jabado N; Pfister SM Cancer Cell; 2012 Oct; 22(4):425-37. PubMed ID: 23079654 [TBL] [Abstract][Full Text] [Related]
7. [Clinicopathological features for epithelioid glioblastoma: A newly defined tumor by the 2016 World Health Organization Classification of Tumors of the Central Nervous System]. Li J; Ling X; Lai M; Hu Q; Shan C; Cai L Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2018 Apr; 43(4):398-402. PubMed ID: 29774876 [TBL] [Abstract][Full Text] [Related]
8. Adult classical glioblastoma with a BRAF V600E mutation. Takahashi Y; Akahane T; Sawada T; Ikeda H; Tempaku A; Yamauchi S; Nishihara H; Tanaka S; Nitta K; Ide W; Hashimoto I; Kamada H World J Surg Oncol; 2015 Mar; 13():100. PubMed ID: 25885250 [TBL] [Abstract][Full Text] [Related]
9. BRAF V600E, TERT promoter mutations and CDKN2A/B homozygous deletions are frequent in epithelioid glioblastomas: a histological and molecular analysis focusing on intratumoral heterogeneity. Nakajima N; Nobusawa S; Nakata S; Nakada M; Yamazaki T; Matsumura N; Harada K; Matsuda H; Funata N; Nagai S; Nakamura H; Sasaki A; Akimoto J; Hirato J; Yokoo H Brain Pathol; 2018 Sep; 28(5):663-673. PubMed ID: 29105198 [TBL] [Abstract][Full Text] [Related]
10. Molecular characteristics and clinical features of multifocal glioblastoma. Dono A; Wang E; Lopez-Rivera V; Ramesh AV; Tandon N; Ballester LY; Esquenazi Y J Neurooncol; 2020 Jun; 148(2):389-397. PubMed ID: 32440969 [TBL] [Abstract][Full Text] [Related]
11. Epithelioid glioblastoma with microglia features: potential for novel therapy. Nakagomi N; Sakamoto D; Hirose T; Takagi T; Murase M; Nakagomi T; Yoshimura S; Hirota S Brain Pathol; 2020 Nov; 30(6):1119-1133. PubMed ID: 32687679 [TBL] [Abstract][Full Text] [Related]
12. Germline SMARCB1 mutation predisposes to multiple meningiomas and schwannomas with preferential location of cranial meningiomas at the falx cerebri. van den Munckhof P; Christiaans I; Kenter SB; Baas F; Hulsebos TJ Neurogenetics; 2012 Feb; 13(1):1-7. PubMed ID: 22038540 [TBL] [Abstract][Full Text] [Related]
13. PDGFRA amplification is common in pediatric and adult high-grade astrocytomas and identifies a poor prognostic group in IDH1 mutant glioblastoma. Phillips JJ; Aranda D; Ellison DW; Judkins AR; Croul SE; Brat DJ; Ligon KL; Horbinski C; Venneti S; Zadeh G; Santi M; Zhou S; Appin CL; Sioletic S; Sullivan LM; Martinez-Lage M; Robinson AE; Yong WH; Cloughesy T; Lai A; Phillips HS; Marshall R; Mueller S; Haas-Kogan DA; Molinaro AM; Perry A Brain Pathol; 2013 Sep; 23(5):565-73. PubMed ID: 23438035 [TBL] [Abstract][Full Text] [Related]
14. Multigene profiling to identify alternative treatment options for glioblastoma: a pilot study. Tabone T; Abuhusain HJ; Nowak AK; ; Erber WN; McDonald KL J Clin Pathol; 2014 Jul; 67(7):550-5. PubMed ID: 24695838 [TBL] [Abstract][Full Text] [Related]
15. Rhabdoid tumor predisposition syndrome caused by SMARCB1 constitutional deletion: prenatal detection of new case of recurrence in siblings due to gonadal mosaicism. Gigante L; Paganini I; Frontali M; Ciabattoni S; Sangiuolo FC; Papi L Fam Cancer; 2016 Jan; 15(1):123-6. PubMed ID: 26342593 [TBL] [Abstract][Full Text] [Related]
16. Epithelial-Myoepithelial Carcinoma: Frequent Morphologic and Molecular Evidence of Preexisting Pleomorphic Adenoma, Common HRAS Mutations in PLAG1-intact and HMGA2-intact Cases, and Occasional TP53, FBXW7, and SMARCB1 Alterations in High-grade Cases. El Hallani S; Udager AM; Bell D; Fonseca I; Thompson LDR; Assaad A; Agaimy A; Luvison AM; Miller C; Seethala RR; Chiosea S Am J Surg Pathol; 2018 Jan; 42(1):18-27. PubMed ID: 29135520 [TBL] [Abstract][Full Text] [Related]
17. Detection of p53 mutations in proliferating vascular cells in glioblastoma multiforme. Kawasoe T; Takeshima H; Yamashita S; Mizuguchi S; Fukushima T; Yokogami K; Yamasaki K J Neurosurg; 2015 Feb; 122(2):317-23. PubMed ID: 25415071 [TBL] [Abstract][Full Text] [Related]
18. Glioblastoma: pathology, molecular mechanisms and markers. Aldape K; Zadeh G; Mansouri S; Reifenberger G; von Deimling A Acta Neuropathol; 2015 Jun; 129(6):829-48. PubMed ID: 25943888 [TBL] [Abstract][Full Text] [Related]
19. Somatic mutations associated with MRI-derived volumetric features in glioblastoma. Gutman DA; Dunn WD; Grossmann P; Cooper LA; Holder CA; Ligon KL; Alexander BM; Aerts HJ Neuroradiology; 2015 Dec; 57(12):1227-37. PubMed ID: 26337765 [TBL] [Abstract][Full Text] [Related]
20. Deep sequencing of multiple regions of glial tumors reveals spatial heterogeneity for mutations in clinically relevant genes. Kumar A; Boyle EA; Tokita M; Mikheev AM; Sanger MC; Girard E; Silber JR; Gonzalez-Cuyar LF; Hiatt JB; Adey A; Lee C; Kitzman JO; Born DE; Silbergeld DL; Olson JM; Rostomily RC; Shendure J Genome Biol; 2014 Dec; 15(12):530. PubMed ID: 25608559 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]